DCM
DNTH icon

Driehaus Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Driehaus Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8M Sell
295,266
-22,046
-7% -$1.93M 0.17% 183
2026
Q1 		$26.6M Buy
+317,312
New +$18.4M 0.2% 164
2021
Q3 		– Sell
-5,000
Closed -$782K – 410
2021
Q2 		$782K Buy
+5,000
New +$918K 0.01% 354

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Driehaus Capital Management's DNTH Position: Q2 2026 in Review

Driehaus Capital Management reduced its Dianthus Therapeutics (DNTH) stake by 6.9% in Q2 2026, selling an estimated $1.93M and leaving 295,266 shares worth $28.8M. The position accounts for 0.17% of the portfolio, ranked #183.

Driehaus Capital Management first reported a position in DNTH in Q2 2021 and has held it in 3 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Driehaus Capital Management held 295,266 shares of Dianthus Therapeutics worth $28.8M as of Q2 2026.
  • Driehaus Capital Management sold 22,046 Dianthus Therapeutics shares in Q2 2026, an estimated $1.93M.
  • Dianthus Therapeutics made up 0.17% of Driehaus Capital Management's portfolio in Q2 2026, its #183 holding.
  • Driehaus Capital Management first reported a position in Dianthus Therapeutics in Q2 2021 and has held it in 3 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.